SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Art Pappas will sit on a panel at the 2007 BIO International Convention titled "Mining for Gold: Top Biotech Venture Capital Markets" in Boston
News | 05. 06. 2007
